Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
Spain
Centro Integral Oncológico Clara Campal (CIOCC) Hospital, Madrid United Kingdom
The Beatson West of Scotland Cancer Centre, Glasgow, Scotland Imperial College Healthcare NHS Trust, Hammersmith Hospital, London Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford